Primary Site >> Biliary tract Cancer
Gene >> CDH3
| 1. | |||||||||||
| Journal: | Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:4-18. | ||||||||||
| Title: | [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept]. | ||||||||||
| Author: | Shirasaka, Tetsuhiko|Taguchi, Tetsuo | ||||||||||
| PMID: | 16897967 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2007 Feb;59(3):285-93. | ||||||||||
| Title: | Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer. | ||||||||||
| Author: | Zhu, Andrew X|Clark, Jeffrey W|Ryan, David P|Meyerhardt, Jeffrey A|Enzinger, Peter C|Earle, Craig C|Fuchs, Charles S|Regan, Eileen|Anbe, Hiroshi|Houghton, Michele|Zhang, Joshua|Urrea, Peter|Kulke, Matthew H | ||||||||||
| PMID: | 16786333 | ||||||||||
| 3. | |||||||||||
| Journal: | Hum Pathol. 2010 Nov;41(11):1558-65. | ||||||||||
| Title: | Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. | ||||||||||
| Author: | Riener, Marc-Oliver|Vogetseder, Alexander|Pestalozzi, Bernhard C|Clavien, Pierre-Alain|Probst-Hensch, Nicole|Kristiansen, Glen|Jochum, Wolfram | ||||||||||
| PMID: | 20621328 | ||||||||||
| 4. | |||||||||||
| Journal: | Anat Cell Biol. 2010 Jun;43(2):110-7. | ||||||||||
| Title: | CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells. | ||||||||||
| Author: | Baek, Sungmin|Lee, Yong-Whan|Yoon, Sik|Baek, Sun-Yong|Kim, Bong-Seon|Oh, Sae-Ock | ||||||||||
| PMID: | 21189991 | ||||||||||
| 5. | |||||||||||
| Journal: | J Transl Med. 2014 Mar 7;12:61. | ||||||||||
| Title: | Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer. | ||||||||||
| Author: | Aruga, Atsushi|Takeshita, Nobuhiro|Kotera, Yoshihito|Okuyama, Ryuji|Matsushita, Norimasa|Ohta, Takehiro|Takeda, Kazuyoshi|Yamamoto, Masakazu | ||||||||||
| PMID: | 24606884 | ||||||||||